会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 1. 发明授权
    • Aminopeptidase inhibitors
    • 氨肽酶抑制剂
    • US4714757A
    • 1987-12-22
    • US777121
    • 1985-09-18
    • Eric M. GordonJollie D. Godfrey, Jr.Norma G. Delaney
    • Eric M. GordonJollie D. Godfrey, Jr.Norma G. Delaney
    • C07K5/02
    • C07K5/02
    • Aminopeptidase inhibitory activity is exhibited by compounds having the formula ##STR1## and pharmaceutically acceptable salts thereof, wherein R.sub.1 and R.sub.2 are each independently hydrogen, alkyl, carboxyalkyl, halo-substituted alkyl, hydroxyalkyl, aminoalkyl, mercaptoalkyl, alkylthioalkyl, (cycloalkyl)alkyl, (heteroaryl)alkyl, arylalkyl, carbamoylalkyl, guanidinylalkyl or heteroaryl;R.sub.3 is hydrogen, alkyl, cycloalkyl, aryl, heteroaryl, arylalkyl, (heteroaryl)alkyl, ##STR2## R.sub.4 and R.sub.5 are each independently hydrogen, alkyl, cycloalkyl, aryl, heteroaryl, arylalkyl, or (heteroaryl)alkyl;A is glycyl, alanyl, leucyl, phenylalanyl, arginyl, sarcosyl, seryl, asparagyl, lysyl, glutamyl, histidyl, tryptophyl, cysteinyl, methionyl, threonyl, tyrosyl, valyl, aspartyl, prolyl, norleucyl, or norvalyl; andn is an integer of 1 to 6.
    • 氨基肽酶抑制活性由具有下式的化合物及其药学上可接受的盐显示,其中R 1和R 2各自独立地为氢,烷基,羧基烷基,卤素取代的烷基,羟基烷基,氨基烷基,巯基烷基,烷硫基烷基,(环烷基)烷基, (杂芳基)烷基,芳基烷基,氨基甲酰基烷基,胍基烷基或杂芳基; R 3是氢,烷基,环烷基,芳基,杂芳基,芳基烷基,(杂芳基)烷基,+ R CH 2 NR 4 R 5; R 4和R 5各自独立地为氢,烷基,环烷基,芳基,杂芳基,芳烷基或(杂芳基)烷基; A是甘氨酰,丙氨酰,亮氨酰,苯丙氨酰,精氨酰,肌氨酰,丝氨酰,天冬酰胺,赖氨酰,谷氨酰,组氨酰,色氨酰,半胱氨酰,甲硫氨酰,苏氨酰,酪氨酰,缬氨酰,天冬氨酰,脯氨酰, n为1〜6的整数。
    • 2. 发明授权
    • Amino thiol peptides
    • 氨基硫醇肽
    • US4636560A
    • 1987-01-13
    • US672044
    • 1984-11-16
    • Jollie D. Godfrey, Jr.Eric M. GordonNorma G. Delaney
    • Jollie D. Godfrey, Jr.Eric M. GordonNorma G. Delaney
    • C07D521/00A61K31/16A61K31/165A61K31/195A61K31/215A61K31/22A61K38/00A61K38/55A61P25/04A61P43/00C07C67/00C07C313/00C07C323/25C07C323/26C07C323/29C07C323/44C07C323/58C07C323/60C07K5/04C07K5/06C07K5/065C07K5/072C07K5/083C07K5/09C07K5/103C07K7/06C07K14/81C07C149/273
    • C07K5/1008C07C323/44C07K5/06043C07K5/06078C07K5/06095C07K5/0804C07K5/0815A61K38/00Y10S530/80
    • Analgesic and hypotensive activity is exhibited by compounds having the formula ##STR1## and pharmaceutically acceptable salts thereof, wherein R.sub.1 and R.sub.2 are each independently hydrogen, alkyl, carboxyalkyl, halo substituted alkyl, hydroxyalkyl, aminoalkyl, mercaptoalkyl, alkylthioalkyl, (cycloalkyl)alkyl, (heteroaryl)alkyl, arylalkyl, carbamoylalkyl, guanidinylalkyl, or heteroaryl;R.sub.3 is hydroxy, alkoxy, (substituted alkyl)oxy, arylalkoxy, (heteroaryl)alkoxy, or --NY.sub.1 Y.sub.2, wherein Y.sub.1 and Y.sub.2 are each independently hydrogen, alkyl, aryl, or arylalkyl, or Y.sub.1 is hydrogen and Y.sub.2 is substituted alkyl or (heteroaryl)alkyl;A.sub.1 is glycyl, alanyl, leucyl, phenylalanyl, arginyl, sarcosyl, seryl, asparagyl, lysyl, glutamyl, histidyl, tryptophyl, cysteinyl, methionyl, threonyl, tyrosyl, leucyl, valyl, aspartyl, prolyl, norleucyl, norvalyl, or ##STR2## wherein n.sub.6 is an integer of 2 to 15; A.sub.2, A.sub.3, A.sub.4 and A.sub.5 each is independently glycyl, alanyl, leucyl, phenylalanyl, arginyl, sarcosyl, seryl, asparagyl, lysyl, glutamyl, histidyl, tryptophyl, cysteinyl, methionyl, threonyl, tyrosyl, leucyl, valyl, aspartyl, prolyl, norleucyl, or norvalyl; andn.sub.1, n.sub.2, n.sub.3, n.sub.4 and n.sub.5 each is independently 0 or 1.
    • 具有式(IMA)> TR(A1)n1(A2)n2(A3)n3(A4)n4(A5)n5R3的化合物及其药学上可接受的盐,其中R1和R2各自独立地表现出止痛和降血压活性 氢,烷基,羧基烷基,卤素取代的烷基,羟基烷基,氨基烷基,巯基烷基,烷硫基烷基,(环烷基)烷基,(杂芳基)烷基,芳基烷基,氨基甲酰基烷基,胍基烷基或杂芳基; R3是羟基,烷氧基,(取代的烷基)氧基,芳基烷氧基,(杂芳基)烷氧基或-NY1Y2,其中Y1和Y2各自独立地是氢,烷基,芳基或芳烷基,或Y1是氢,Y2是取代的烷基或( 杂芳基)烷基; A1是甘氨酰基,丙氨酰基,亮氨酰基,苯丙氨酰,精氨酰,肌氨酰,丝氨酰,天冬酰胺基,赖氨酰,谷氨酰,组氨酸,色氨酸,半胱氨酰,甲硫氨酰,苏氨酰,酪氨酰,亮氨酰,缬氨酰,天冬氨酰,脯氨酰, 其中n6为2至15的整数; A2,A3,A4和A5各自独立地为甘氨酰,丙氨酰,亮氨酰,苯丙氨酰,精氨酰,肌氨酰,丝氨酰,天冬酰胺酰基,赖氨酰,谷氨酰,组氨酰,色氨酰,半胱氨酰,甲硫氨酰,苏氨酰,酪氨酰,亮氨酰,缬氨酰,天冬氨酰, 正亮片或正戊基; n1,n2,n3,n4和n5各自独立地为0或1。